Shaked Ron, Katz Michael, Cohen-Dvashi Hadas, Diskin Ron
Department of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.
Proc Natl Acad Sci U S A. 2025 Jul 15;122(28):e2505505122. doi: 10.1073/pnas.2505505122. Epub 2025 Jul 9.
The human endogenous retrovirus K (HERV-K) is a retrovirus that got assimilated into the human genome in ancient times and has been inherited in our germline ever since. It enters cells using a class-I spike protein (Env) that mediates receptor recognition and membrane fusion. On top of having a biological role during development, HERV-K is activated in amyotrophic lateral sclerosis, various cancers, and other pathological conditions. Antibodies that target the HERV-K spike complex have therapeutic value, flagging the spike as a novel drug target. Here, we use cryo-EM to determine the trimeric structure of the HERV-K spike. The spike presents a distinct structure, which substantially differs from other class-I fusogens. Nevertheless, some general architectural features suggest a common origin with other retroviruses. The ability to structurally characterize the HERV-K spike may facilitate the development of antibody-based therapies.
人类内源性逆转录病毒K(HERV-K)是一种在古代就被整合到人类基因组中的逆转录病毒,此后一直在我们的种系中遗传。它利用一种I类刺突蛋白(Env)进入细胞,该蛋白介导受体识别和膜融合。除了在发育过程中具有生物学作用外,HERV-K在肌萎缩侧索硬化症、各种癌症和其他病理状况中被激活。靶向HERV-K刺突复合体的抗体具有治疗价值,将该刺突标记为一个新的药物靶点。在这里,我们使用冷冻电镜来确定HERV-K刺突的三聚体结构。该刺突呈现出独特的结构,与其他I类融合蛋白有很大不同。然而,一些一般的结构特征表明它与其他逆转录病毒有共同的起源。对HERV-K刺突进行结构表征的能力可能会促进基于抗体的治疗方法的开发。